Security key
15117F500
Cellectar Biosciences, Inc. - Common Stock (CLRB)
CUSIP: 15117F500
Q4 2019 13F Holders as of 31 Dec 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,719,970
- Total 13F shares
- 1,295,959
- Share change
- -253,824
- Total reported value
- $2,917,000
- Price per share
- $2.25
- Number of holders
- 9
- Value change
- -$498,988
- Number of buys
- 2
- Number of sells
- 7
Report period
Q4 2019
Institutions
9
Top holders
9
CLRB full security history
Newer quarter: Q1 2020
Previous quarter: Q3 2019
Cellectar Biosciences, Inc. SEC filings
Cellectar Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117F500
Recent filing periods:
Top shareholders of CLRB - Cellectar Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Boxer Capital, LLC |
13F
|
Company |
11%
|
920,000
|
$1,840,000 | — | 30 Sep 2019 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.7%
|
235,701
|
$471,000 | — | 30 Sep 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2%
|
176,902
|
$354,000 | — | 30 Sep 2019 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1%
|
87,500
|
$175,000 | — | 30 Sep 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.37%
|
32,221
|
$64,000 | — | 30 Sep 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.19%
|
16,755
|
$34,000 | — | 30 Sep 2019 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.15%
|
13,400
|
$20,000 | — | 30 Sep 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.12%
|
10,505
|
$21,000 | — | 30 Sep 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0.1%
|
9,000
|
$18,000 | — | 30 Sep 2019 | |
| US BANCORP \DE\ |
13F
|
Company |
0.03%
|
2,857
|
$6,000 | — | 30 Sep 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.01%
|
1,291
|
$3,000 | — | 30 Sep 2019 | |
| Kelly Financial Services LLC |
13F
|
Company |
0%
|
27
|
$54 | — | 30 Sep 2019 |
Institutional Holders of Cellectar Biosciences, Inc. - Common Stock (CLRB) as of Q4 2019
As of 31 Dec 2019,
Cellectar Biosciences, Inc. - Common Stock (CLRB) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,295,959 shares.
The largest 9 holders included
BOXER CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, SPHERA FUNDS MANAGEMENT LTD., Game Plan Financial Advisors, LLC, VANGUARD GROUP INC, MORGAN STANLEY, PNC Financial Services Group, Inc., LADENBURG THALMANN FINANCIAL SERVICES INC., and US BANCORP \DE\.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2019 vs Q3 2019 Across Filers
Q3 2019 holders
12
Q4 2019 holders
9
Holder diff
-3
| Investor | Q3 2019 Shares | Q4 2019 Shares | Share Diff | Share Chg % | Q3 2019 Value $ | Q4 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.